BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 20049931)

  • 1. Inpatient use of laxatives during opioid administration in children with sickle cell disease.
    O'Brien SH; Fan L; Kelleher KJ
    Pediatr Blood Cancer; 2010 Apr; 54(4):559-62. PubMed ID: 20049931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of opioids and laxatives, and incidence of constipation, in patients requiring neck-of-femur (NOF) surgery: a pilot study.
    Davies EC; Green CF; Mottram DR; Pirmohamed M
    J Clin Pharm Ther; 2008 Oct; 33(5):561-6. PubMed ID: 18834372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of opioids, anticholinergic medications and disease progression on the prescription of laxatives in hospitalized palliative care patients: a retrospective analysis.
    Clark K; Lam LT; Agar M; Chye R; Currow DC
    Palliat Med; 2010 Jun; 24(4):410-8. PubMed ID: 20348271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis for opioid-induced constipation in elderly long-term care residents: a cross-sectional study of Medicare beneficiaries.
    Max EK; Hernandez JJ; Sturpe DA; Zuckerman IH
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):129-36. PubMed ID: 17719515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in receipt of opioids by pediatric oncology patients who died in children's hospitals.
    Orsey AD; Belasco JB; Ellenberg JH; Schmitz KH; Feudtner C
    Pediatr Blood Cancer; 2009 Jul; 52(7):761-6. PubMed ID: 18989880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of childhood constipation by primary care physicians: efficacy and predictors of outcome.
    Borowitz SM; Cox DJ; Kovatchev B; Ritterband LM; Sheen J; Sutphen J
    Pediatrics; 2005 Apr; 115(4):873-7. PubMed ID: 15805358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
    Buchanan ID; Woodward M; Reed GW
    Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescribing of pain medication in palliative care. A survey in general practice.
    Borgsteede SD; Deliens L; Zuurmond WW; Schellevis FG; Willems DL; Van der Wal G; van Eijk JT
    Pharmacoepidemiol Drug Saf; 2009 Jan; 18(1):16-23. PubMed ID: 18985638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of an electronic medical record design modification on laxative co-prescribing among hospitalised patients taking opioids: A before-and-after study.
    Liu S; Gnjidic D; Patanwala AE; Rubin G; Nielsen M; Penm J
    Int J Med Inform; 2020 Aug; 140():104172. PubMed ID: 32473568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laxative management in ambulatory cancer patients on opioid therapy: a prospective, open-label investigation of polyethylene glycol, sodium picosulphate and lactulose.
    Wirz S; Nadstawek J; Elsen C; Junker U; Wartenberg HC
    Eur J Cancer Care (Engl); 2012 Jan; 21(1):131-40. PubMed ID: 21880080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Associated With the Prophylactic Prescription of a Bowel Regimen to Prevent Opioid-Induced Constipation.
    Chen NY; Nguyen E; Schrager SM; Russell CJ
    Hosp Pediatr; 2016 Nov; 6(11):677-683. PubMed ID: 27803072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of senna to prevent problematic constipation in pediatric oncology patients receiving opioids: a multicenter study of clinically detailed administrative data.
    Feudtner C; Freedman J; Kang T; Womer JW; Dai D; Faerber J
    J Pain Symptom Manage; 2014 Aug; 48(2):272-80. PubMed ID: 24321507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of enteral naloxone to treat opioid-induced constipation in a pediatric intensive care unit.
    Tofil NM; Benner KW; Faro SJ; Winkler MK
    Pediatr Crit Care Med; 2006 May; 7(3):252-4. PubMed ID: 16575353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Children with sickle cell disease and human immunodeficiency virus-1 infection: use of inpatient care services in the United States.
    Kourtis AP; Bansil P; Johnson C; Meikle SF; Posner SF; Jamieson DJ
    Pediatr Infect Dis J; 2007 May; 26(5):406-10. PubMed ID: 17468650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of constipation in palliative care patients.
    Clemens KE; Klaschik E
    Curr Opin Support Palliat Care; 2008 Mar; 2(1):22-7. PubMed ID: 18685390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Missed Opportunity to Deprescribe: Docusate for Constipation in Medical Inpatients.
    MacMillan TE; Kamali R; Cavalcanti RB
    Am J Med; 2016 Sep; 129(9):1001.e1-7. PubMed ID: 27154771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Opioid-Induced Constipation in Hospice Patients.
    Sera L; McPherson ML
    Am J Hosp Palliat Care; 2018 Feb; 35(2):330-335. PubMed ID: 28423917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-institutional study analyzing effect of prophylactic medication for prevention of opioid-induced gastrointestinal dysfunction.
    Ishihara M; Ikesue H; Matsunaga H; Suemaru K; Kitaichi K; Suetsugu K; Oishi R; Sendo T; Araki H; Itoh Y;
    Clin J Pain; 2012 Jun; 28(5):373-81. PubMed ID: 22156893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Day hospital versus inpatient management of uncomplicated vaso-occlusive crises in children with sickle cell disease.
    Raphael JL; Kamdar A; Wang T; Liu H; Mahoney DH; Mueller BU
    Pediatr Blood Cancer; 2008 Sep; 51(3):398-401. PubMed ID: 18300322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic management of constipation in the critically ill patient.
    Patanwala AE; Abarca J; Huckleberry Y; Erstad BL
    Pharmacotherapy; 2006 Jul; 26(7):896-902. PubMed ID: 16803421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.